MIA researchers feature on prestigious Highly Cited Researchers 2021 List

MIA researchers feature on prestigious Highly Cited Researchers 2021 List

19 November 2021

Melanoma Institute Australia is proud to announce that MIA’s Co-Medical Directors, Professor Georgina Long AO and Professor Richard Scolyer AO, as well as MIA Faculty members Associate Professor Alex Menzies and Associate Professor Matt Carlino, and former Faculty member Professor Rick Kefford AM, have all been named on the annual Highly Cited Researchers™ 2021 list from Clarivate.

The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe. It identifies the ‘One in 1,000’ Citation Elite – the researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade. Their names are drawn from the publications that rank in the top 1% by citations for field and publication year in the Web of Science™ citation index.

According to Clarivate, 6,602 researchers from more than 70 countries and regions have been recognized this year. Australia has narrowly overtaken Germany to come in fourth, with 332 researchers making the list- remarkable for a country of 25 million compared with Germany’s 83 million.

David Pendlebury, Senior Citation Analyst at the Institute for Scientific Information at Clarivate said:

‘It is increasingly important for nations and institutions to recognize and support the exceptional researchers who are driving the expansion of the world’s knowledge. This list identifies and celebrates exceptional individual researchers at Melanoma Institute Australia who are having a significant impact on the research community as evidenced by the rate at which their work is being cited by their peers. The research they have contributed is fuelling the innovation, sustainability, health and security that is key for our society’s future.’

Melanoma Institute Australia CEO Matthew Browne said the inclusion of four current members of MIA’s Faculty on the global list for the second year running was indicative of our standing on the world stage.

‘To have MIA researchers feature so prominently in the ‘who’s who’ of the world’s scientific elite shows the life-changing impact of our work not only in Australia but internationally,’ he said. ‘Under the leadership of our Co-Medical Directors, Professor Georgina Long AO and Professor Richard Scolyer AO, MIA continues to reach new heights and spearhead the world towards a cure for not only melanoma, but increasingly other complex skin cancers as well. On behalf of the entire MIA team, and our patients, their families and our wonderfully supportive community and donors, I extend my heartfelt congratulations to our four Faculty members named on the Highly Cited Researchers list.’

The full 2021 Highly Cited Researchers list and executive summary can be found online here.

Melanoma Institute Australia is affiliated with The University of Sydney

#highlycited2021 

Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
27 Apr 2018

Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma

For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.

The inspiring story of Emma Betts premieres on Australian Story
16 Apr 2018

The inspiring story of Emma Betts premieres on Australian Story

'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma. 

Toyota helps tackle Australia's national cancer - melanoma
09 Apr 2018

Toyota helps tackle Australia's national cancer - melanoma

Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.

Tackling the Kokoda Trail for melanoma
06 Apr 2018

Tackling the Kokoda Trail for melanoma

Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.

Professor Richard Scolyer presents at world's largest annual meeting of pathologists
29 Mar 2018

Professor Richard Scolyer presents at world's largest annual meeting of pathologists

Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.

Congratulations to Kaye Oakley
29 Mar 2018

Congratulations to Kaye Oakley

A round of applause for a well deserved win.

Farewell from Carole Renouf, CEO of Melanoma Institute Australia
26 Mar 2018

Farewell from Carole Renouf, CEO of Melanoma Institute Australia

A message from our CEO, Carole Renouf

Marching in the twilight
26 Mar 2018

Marching in the twilight

Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma. 

Researchers uncover treatment sequence for advanced melanoma patients
23 Mar 2018

Researchers uncover treatment sequence for advanced melanoma patients

Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.

An unsung hero of melanoma care for nearly 30 years
22 Mar 2018

An unsung hero of melanoma care for nearly 30 years

Melanoma treatment has come a long way in recent times, and the role that nurses play caring for melanoma patients has changed dramatically too.

Sharing our research on melanoma surgery
21 Mar 2018

Sharing our research on melanoma surgery

MIA is sharing it's research with the global surgical oncology community this week at the Society of Surgical Oncology Annual Cancer Symposium.

14 Melanoma Marches down, 7 to go!
19 Mar 2018

14 Melanoma Marches down, 7 to go!

It was a massive weekend of Melanoma Marches with six Marches in: Bendigo, Canberra, Manly, Newcastle, Bunbury and Adelaide.

Melanoma March keeps marching
14 Mar 2018

Melanoma March keeps marching

Weekend two hit the ground marching with Melanoma Marches in Wollongong, Townsville, Mandurah and Western Sydney.

Melanoma March kicks off for 2018
08 Mar 2018

Melanoma March kicks off for 2018

Melanoma Institute Australia's annual fundraising initiative is all systems go!

Calls for urgent crackdown on illegal backyard solariums
07 Mar 2018

Calls for urgent crackdown on illegal backyard solariums

The reported proliferation of illegal commercial solariums is costing lives and requires urgent government intervention.

15-year-old melanoma survivor Toby Rayner will lead Mount Gambier's march against melanoma
28 Feb 2018

15-year-old melanoma survivor Toby Rayner will lead Mount Gambier's march against melanoma

15-year-old melanoma survivor Toby Rayner will lead Mount Gambier’s march against melanoma Julie-Ann Sams knows all too well that melanoma doesn’t discriminate. 

Excision margins for melanoma redefined
21 Feb 2018

Excision margins for melanoma redefined

Updated guidelines defining appropriate excision margins have been published thanks to research from MIA. 

A Pawsome Story of Hope
21 Feb 2018

A Pawsome Story of Hope

Joanne and her trusty companion Frankie spend their days spreading a message of hope in hospitals, nursing homes, even prisons. It is a long way from her darkest hour facing palliative care. This is her story of hope.

A new generation of melanoma researchers
15 Feb 2018

A new generation of melanoma researchers

Melanoma impacts more Australian teenagers and young adults than any other cancer. Dr James Wilmott, who has a young family of his own, has devoted his career to determining why these young Australians are susceptible to melanoma, and importantly, how to save them.

Melanoma Masterclass celebrates Australian luminaries who have transformed melanoma treatment worldwide
13 Feb 2018

Melanoma Masterclass celebrates Australian luminaries who have transformed melanoma treatment worldwide

The extraordinary contribution of Australia’s most distinguished melanoma clinicians and researchers is being celebrated today.